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Mark Cave outlines in-vitro 
methods that are reducing the 
costs of assessing the human health 
risks of soils. 
dose that reaches the central (blood) compartment 
from the gastrointestinal tract1. This is distinct from 
the oral bioaccessibility of a substance, which is defined 
as the fraction that is soluble in the gastrointestinal 
environment and is available for absorption1. 
The use of total contaminant concentrations in soils 
provides a conservative approach as it assumes that all of 
the metal present in the soil can enter the bloodstream. 
Results from animal tests2 suggest that contaminants in 
a soil matrix maybe absorbed to a lesser extent and show 
fewer toxic effects compared to the same concentration 
of soluble salts of the contaminants in a food or liquid 
matrix. In many cases there is no distinction made 
between the intake for contaminants that are bound to 
soil and those which occur as a vapour or are released 
during processes like digestion into solution (the 
bioaccessible fraction). For example, children may ingest 
arsenic-contaminated soil by eating soil or putting dirty 
hands or soiled toys in their mouths. Empirical studies 
have sought to demonstrate a relationship between the 
type of contaminated soil and the fraction of arsenic that 
can be dissolved by digestion3. Using such studies may 
improve our knowledge of the intake of bioaccessible 
organic and inorganic compounds in the future, as this 
parameter represents a better estimate of exposure than 
total concentration of soil contaminants.
IN-VIVO AND IN-VITRO METHODS
Since bioavailability data is essentially related to 
the amount of contaminant in the animal/human 
bloodstream, the data must be produced from the dosing 
of animals with contaminated soil and the subsequent 
measurement of the contaminant in the blood or organs 
of the animal; these are known as in-vivo animal models. 
Bioaccessibility data, however, is normally determined 
in a test-tube environment (in vitro) and represents the 




Quantitative guidelines for assessing risks from potentially harmful elements in soil are associated with several scientific problems. 
There are difficulties in establishing concentrations 
of contaminants beyond which risks from exposure 
to these contaminants would be unacceptable. This 
requires not only scientific (toxicological) information 
on the health effects, but also an element of judgement 
on what is unacceptable risk. In addition, soil is only 
one of the sources of contaminant exposure, and its 
effect, and the cost of dealing with it, needs to be kept 
in proportion with the total exposure to contaminants 
from all sources.
Whether contaminated soils pose a human health risk 
depends on the potential of the contaminant to leave 
the soil and enter the human bloodstream. In terms 
of human health risk assessment there are three main 
exposure pathways for a given contaminant present in 
soil. The largest area of concern is the oral/ingestion 
pathway, followed by the dermal and respiratory 
exposure routes1. 
There is, therefore, a clear need for a practical methodology 
that measures the fraction of the contaminant in the soil 
that, through oral ingestion, can enter the systemic 
circulation of the human body and cause toxic effects. 
This is known as the oral bioavailability and can be 
formally defined as the fraction of an administered 
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tract prior to crossing the mucosal walls. The amount 
of pollutant that is actually absorbed by an organism 
is generally less than or equal to the amount that is 
mobilised1. In-vivo dosing trials have used a variety 
of animal species such as rats and rabbits, but species 
that have similar gastrointestinal tract characteristics to 
human children, such as immature swine, are preferred 
and have been shown to be reasonable analogues for 
children4. In this type of testing, known amounts of 
contaminant are added to the feed of the species being 
tested, in the form of soluble salts or contaminated 
materials. Bioaccessibility extraction tests are generally 
based around the gastrointestinal parameters of young 
children of up to three years of age, since they are 
thought to be most at risk from accidental ingestion of 
soil. Also, since children can absorb a higher percentage 
of contaminant through the digestive system than adults, 
they are more susceptible to adverse health effects5.
Mammal dosing trials are time-consuming and 
expensive. To supersede the use of animals in 
determining the bioavailability of potentially harmful 
elements for human health risk assessment, or to estimate 
bioavailability where animal studies are not available, a 
potential alternative is the use of in-vitro tests. 
In-vitro testing regimes are used as predictors, as they 
do not provide absolute bioavailability data, since this 
can only be done at present by in-vivo techniques. As the 
cost and time required to perform in-vitro techniques 
is small in comparison to in-vivo methods, a larger 
number of soils can be assessed to fully characterise 
a site. A number of in-vitro bioaccessibility tests for 
mimicking human ingestion have been reported in the 
literature and have been comprehensively reviewed6,7. 
Of these, there are four batch extraction methods that 
are most commonly used: the physiologically based 
extraction test (PBET) originally developed by Ruby 
et al. (1996)3; the in-vitro gastrointestinal method (IVG)8; 
the Dutch National Institute for Public Health and the 
Environment method (RIVM)6,9,7  which is mainly used 
in Europe; and the relative bioaccessibility leaching 
procedure (RBALP) which was developed specifically 
for lead in soils10. The PBET, IVG, and RIVM methods 
use extraction media that closely mimic the chemical 
environment of the human gastrointestinal system, 
i.e. they are physiologically based, whereas the RBALP 
uses the physiologically relevant pH of the stomach 
but uses a glycine buffer as the extraction medium. As 
a result of research carried out by the Bioaccessibility 
Research Group of Europe (BARGE) and other research 
groups, it was clear that the different bioaccessibility 
tests showed similar trends when used on the same 
soil samples, but the different operating conditions 
for each test produced wide-ranging bioaccessibility 
values between the methods11. To overcome this problem, 
BARGE took a joint decision to progress the development 
of a harmonised in-vitro bioaccessibility method (the 
unified BARGE method – UBM)12 as seen in Figure 1. 
p Figure 1. Schematic outline of the BARGE unified method
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The main criteria for the test were:
• it should be physiologically based, mimicking 
the human physico-chemical environment in the 
stomach and small intestine. This should help 
to obtain good agreement with in-vivo data and 
enhance public understanding of the test;
• it should represent a conservative case;
• there should be one set of conditions for all 
potentially harmful elements (PHE) being studied;
• it must be demonstrated that the test is a good 
analogue of in-vivo conditions; and
• the test must be able to produce repeatable and 
reproducible results within and between testing 
laboratories.
The chosen method was the RIVM method9 as this was 
considered to be the most suitable static or batch method 
available, and therefore more likely to be adopted by 
testing laboratories. The RIVM methodology has also 
gained acceptance by regulators in both the Netherlands 
and Denmark. Modifications were made to the RIVM 
methodology to ensure adequate conservatism and that 
the in-vitro test was robust and applicable to the different 
soil types found in a range of different countries. 
A schematic outline of the method is shown in Figure 1. 
The UBM has now undergone initial inter-laboratory 
trials13 and been validated against an in-vivo model2. 
It has become widely accepted as the method of choice 
in European countries.
p  Figure 2: Estimated bioaccessible lead in topsoils in the Greater London area; solid lines indicate roads 
(Source: Ordnance Survey Strategic data © Crown copyright 2012)16
August 2012 | Environmental Scientist | 29
FEATURE
WIDER IMPACTS OF MEASURING BIOACCESSIBILITY
In a study of the financial impact of research carried out 
for the NERC (Natural Environment Research Council) 
by BGS (the British Geological Survey)14, examples of the 
use of bioaccessibility testing were given that showed 
that:
• in one case the assessment enabled the re-use 
of existing site materials as part of the land-
remediation process, which subsequently led to 
reduced costs of approximately £3.75 million. In 
addition, approximately 3,750 lorry trips to landfill 
were avoided and 105 tonnes of carbon-dioxide 
equivalent were saved; and 
• in another example, BGS worked with Land Quality 
Management and University of Nottingham staff 
to save between £7 million and £30 million in 
remediation expenses on one site. The more accurate 
bioaccessibility testing not only reassured local 
residents, but also allowed the stalled housing 
market in the area to restart. 
Across England, there are an estimated 15,470 ha of land 
in need of remediation. The cost of remediating this 
land is between £100,000 and £325,000 per ha, giving a 
potential market of £1.5 billion to £5.0 billion. 
The research methods developed by BGS have the 
potential to save between £3.9 million and £12.6 million 
per year in remediating derelict land for development. 
Over a 20-year period, these cost savings are estimated 
to have a Net Present Value of between £55 million and 
£179 million.
The method is also being used on a national scale to 
provide bioaccessibility maps for arsenic and lead15,16. 
Figure 2 shows an example of how a combination of the 
UBM test and data modelling has produced a map of the 
bioaccessible lead in soils in the Greater London area.
 Bioaccessibility testing cuts across a number of disciplines 
including chemistry, geochemistry, toxicology, human 
health and risk assessment, and recent collaborative work 
untaken by research consortia such as the BARGE group 
have enabled the development of standardised testing 
protocols that have had a direct impact on human health 
risk assessment and demonstrable economic benefits 
when used on a national and international scale.
Mark Cave is a Principal Scientist at the British Geological 
Survey where he is manager of a project on  Environment and 
Health research within the Geochemical Baselines and Medical 
Geology team, he is also Chairman of the Bioaccessibility 
Research Group of Europe.
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